securities class action

$SLNO faces securities lawsuit alleging misleading safety claims for hyperphagia drug VYKAT XR. Stock crashed 40% after short seller report and management admissions of launch disruptions.

Lakeland Industries faces securities class action alleging CEO and CFO made misleading statements about acquisitions and financial guidance, resulting in shareholder losses.

Law firm Levi & Korsinsky seeks investors in Inovio Pharmaceuticals securities class action alleging failure to disclose manufacturing delays and FDA's standard review decision.

Securities class action filed against $SNOW alleging officers made materially misleading statements about revenue growth and 2029 targets, triggering 18% stock decline.

NuScale shareholders sue Fluor over $495M ENTRA1 payment that preceded 70% stock collapse, alleging inadequate board oversight of misrepresentations.

Securities class action filed against BellRing Brands for allegedly mischaracterizing retailer inventory buildup as organic demand growth, later contradicting earlier guidance.

Enphase Energy CEO and CFO named as defendants in securities class action over alleged misleading statements regarding inventory levels and 25D Credit impact.

Law firm probing Soleno Therapeutics for allegedly concealing safety data on drug DCCR. Investors must file claims by May 5, 2026.

Varonis faces class action lawsuit over alleged concealment of 63.9% term license revenue decline. Stock crashed 48%, erasing $3.8 billion in value.

Rosen Law Firm recruits Plug Power investors for class action alleging false DOE loan and facility construction statements. Filing deadline approaching.

Rosen Law Firm recruits lead plaintiffs in securities class action against Paysafe Limited, alleging false statements about high-risk client exposure, undisclosed credit losses, and missed financial guidance.

Hub Group restated Q1-Q3 2025 financials after discovering accounting errors in transportation costs. Stock fell 18.3% as investors face potential securities litigation.

$EDR investors face March 18 deadline to join securities class action alleging false share valuations, improper compensation disclosure, and merger conflicts of interest.

Ardent Health faces securities lawsuit over accounting practices; investors with $100K+ losses urged to seek counsel before March 9, 2026 deadline.

BellRing Brands faces securities lawsuits alleging misrepresented sales growth driven by inventory stockpiling. Lead plaintiff deadline: March 23, 2026.

RegenxBio faces securities class action alleging misleading RGX-111 gene therapy claims; investors have until April 14, 2026 to file.

Rosen Law Firm urges $BBWI investors with losses exceeding $100K to file claims by March 16, 2026 deadline in securities class action over alleged misstatements.

Rosen Law Firm urges Beyond Meat investors to join class action lawsuit over alleged false statements regarding asset valuations. Lead plaintiff deadline: March 24, 2026.

Rosen Law Firm urges Richtech Robotics ($RR) investors to join securities class action alleging false Microsoft partnership claims. Lead plaintiff deadline is April 3, 2026.

Investors in $MREO have until April 6, 2026 to join securities class action alleging misleading statements about failed Phase 3 setrusumab trials.